Modeling severe respiratory syncytial virus pathogenesis in bronchopulmonary dysplasia

支气管肺发育不良中严重呼吸道合胞病毒发病机制的建模

基本信息

  • 批准号:
    9981352
  • 负责人:
  • 金额:
    $ 23.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-01 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Currently, the molecular and cellular mechanisms underlying the enhanced disease development of RSV infection in children with bronchopulmonary dysplasia (BPD) is elusive, largely due to the lack of animal studies to model severe RSV infection in this at-risk group of patients. We have recently established a clinically- relevant neonatal hyperoxia model of prematurity and BPD in the lab. In this application, we wish to use this model to examine the mechanisms of severe disease development following RSV infection in BPD hosts. Two specific aims are proposed: Aim1: To test the hypothesis that neonatal hyperoxia predisposes the hosts to severe RSV-associated diseases. Aim 2: To test the hypothesis that exaggerated Gadd45b expression promotes acute RSV-associated diseases in BPD hosts. Relevance statement Respiratory syncytial virus (RSV) is the most frequent cause of serious lower respiratory-tract illness in infants. Severe RSV infection is prominent in preterm infants and particularly dangerous in children with BPD, a chronic lung disease of infants born extremely premature and characterized by abnormal development of structure and function. Of note, the incidence of BPD is increasing globally due to the improved survival rate of extremely premature infants. Following initial hospital discharge of preterm or BPD infants, viral respiratory infections, most commonly with RSV, result in increased hospitalization, healthcare utilization, and increased respiratory morbidity. These clinical data suggest that preterm patients, particularly BPD patients, are highly susceptible to RSV infection and develop severe pulmonary diseases following RSV infection. The knowledge generated from this study will significantly improve our understanding on RSV pathogenicity in BPD hosts. Furthermore, we expect that this application will promise to open the door for novel therapeutic strategies aiming to minimize viral pathogenesis and chronic lung conditions in BPD patients (for instance, targeting on Gadd45b pathway).
项目总结/摘要 目前,RSV增强疾病发展的分子和细胞机制 支气管肺发育不良(BPD)儿童的感染很难确定,主要是由于缺乏动物研究 在这组高危患者中模拟严重RSV感染。我们最近建立了一个临床- 在实验室建立了早产儿和BPD相关的新生儿高氧模型。在本申请中,我们希望使用 模型来检查BPD宿主中RSV感染后严重疾病发展的机制。两 目的1:验证新生儿高氧易患宿主的假设 严重的RSV相关疾病。目的2:检验夸大Gadd 45 b的假设 表达促进BPD宿主中的急性RSV相关疾病。 相关性说明 呼吸道合胞病毒(RSV)是婴儿严重下呼吸道疾病的最常见原因。 严重的RSV感染在早产儿中是突出的,在患有BPD的儿童中特别危险, 早产儿的慢性肺病,特征是肺发育异常, 结构和功能。值得注意的是,BPD的发病率在全球范围内增加,这是由于BPD患者的生存率提高。 极早产儿早产儿或BPD婴儿初次出院后,病毒性呼吸道感染 感染,最常见的是RSV,导致住院治疗,医疗保健利用增加, 呼吸道疾病这些临床数据表明,早产患者,特别是BPD患者, 易受RSV感染并在RSV感染后发展为严重的肺部疾病。知识 本研究的结果将显著提高我们对RSV在BPD宿主中致病性的理解。 此外,我们预计这一应用将有望为新的治疗策略打开大门 旨在最大限度地减少BPD患者的病毒发病机制和慢性肺部疾病(例如,靶向 Gadd 45 b途径)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jie Sun其他文献

Jie Sun的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jie Sun', 18)}}的其他基金

Uncover mechanisms underlying the development of chronic lung sequelae post COVID-19
揭示 COVID-19 后慢性肺部后遗症发生的机制
  • 批准号:
    10734747
  • 财政年份:
    2023
  • 资助金额:
    $ 23.85万
  • 项目类别:
Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma
哮喘儿童恢复期和疫苗诱导的 SARS-CoV-2 粘膜特异性免疫以及值得关注的变体的决定因素
  • 批准号:
    10638521
  • 财政年份:
    2023
  • 资助金额:
    $ 23.85万
  • 项目类别:
Modeling severe respiratory syncytial virus pathogenesis in bronchopulmonarydysplasia
支气管肺发育不良中严重呼吸道合胞病毒发病机制的建模
  • 批准号:
    10515456
  • 财政年份:
    2022
  • 资助金额:
    $ 23.85万
  • 项目类别:
Roles of tissue-resident helper T cells in mucosal immunity against influenzainfection
组织驻留辅助 T 细胞在针对流感感染的粘膜免疫中的作用
  • 批准号:
    10605297
  • 财政年份:
    2022
  • 资助金额:
    $ 23.85万
  • 项目类别:
Roles of tissue-resident helper T cells in mucosal immunity against influenzainfection
组织驻留辅助 T 细胞在针对流感感染的粘膜免疫中的作用
  • 批准号:
    10393621
  • 财政年份:
    2022
  • 资助金额:
    $ 23.85万
  • 项目类别:
Roles of tissue-resident helper T cells in mucosal immunity against influenzainfection
组织驻留辅助 T 细胞在针对流感感染的粘膜免疫中的作用
  • 批准号:
    10515543
  • 财政年份:
    2022
  • 资助金额:
    $ 23.85万
  • 项目类别:
COVID-19 competitive revision: BALANCING PROTECTIVE IMMUNITY AND CHRONIC SEQUELAE BY RESIDENT CD8 T CELLS
COVID-19 竞争性修订:平衡驻留 CD8 T 细胞的保护性免疫和慢性后遗症
  • 批准号:
    10224990
  • 财政年份:
    2020
  • 资助金额:
    $ 23.85万
  • 项目类别:
Elucidating the roles of alveolar macrophage inflammation and self renewal duringinfluenza infection
阐明流感感染期间肺泡巨噬细胞炎症和自我更新的作用
  • 批准号:
    10515526
  • 财政年份:
    2020
  • 资助金额:
    $ 23.85万
  • 项目类别:
Balancing protective immunity and chronic sequelae by resident CD8 T cells
通过常驻 CD8 T 细胞平衡保护性免疫和慢性后遗症
  • 批准号:
    9981307
  • 财政年份:
    2020
  • 资助金额:
    $ 23.85万
  • 项目类别:
Elucidating the roles of alveolar macrophage inflammation and self renewal duringinfluenza infection
阐明流感感染期间肺泡巨噬细胞炎症和自我更新的作用
  • 批准号:
    10652322
  • 财政年份:
    2020
  • 资助金额:
    $ 23.85万
  • 项目类别:

相似海外基金

Improving Acute Disease Management for Patients with Alzheimer's Disease and Related Dementias
改善阿尔茨海默病和相关痴呆症患者的急性疾病管理
  • 批准号:
    10712647
  • 财政年份:
    2001
  • 资助金额:
    $ 23.85万
  • 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
  • 批准号:
    6247642
  • 财政年份:
    1997
  • 资助金额:
    $ 23.85万
  • 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
  • 批准号:
    3718999
  • 财政年份:
  • 资助金额:
    $ 23.85万
  • 项目类别:
Neurophysiological alterations in multiple sclerosis patients during acute disease acivity
多发性硬化症患者急性疾病活动期间的神经生理学变化
  • 批准号:
    465668867
  • 财政年份:
  • 资助金额:
    $ 23.85万
  • 项目类别:
    Research Grants
SIVMAC 1NEF ALLELE: LYMPHOCYTE ACTIVATION & ACUTE DISEASE IN MACAQUE MONKEYS
SIVMAC 1NEF 等位基因:淋巴细胞激活
  • 批准号:
    3719026
  • 财政年份:
  • 资助金额:
    $ 23.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了